---
title: "Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel in treatment of patients with vascular trauma"
date: "2023-09-13T09:12:47.000Z"
publishedDate: "13 septembre 2023"
summary: "Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair. A press release reports that the single-arm clinical trial was a success and showed that the HAV in this study had higher rates of patency, and lower rates of amputation and infection, [&#8230;] The post Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel in treatment of patients with vascular trauma appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/humacyte-announces-positive-top-line-results-from-phase-2-3-trial-of-human-acellular-vessel-in-treatment-of-patients-with-vascular-trauma/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-09-13-humacyte-announces-positive-top-line-results-from-phase-23-trial-of-human-acellular-vessel-in-treatment-of-patients-with-vascular-trauma"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/humacyte-announces-positive-top-line-results-from-phase-2-3-trial-of-human-acellular-vessel-in-treatment-of-patients-with-vascular-trauma/"
---

![Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel in treatment of patients with vascular trauma](https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/humacyte-announces-positive-top-line-results-from-phase-2-3-trial-of-human-acellular-vessel-in-treatment-of-patients-with-vascular-trauma/*

## L’essentiel

Humacyte has announced positive top line results from its V005 Phase 2/3 trial of the Human Acellular Vessel (HAV) in vascular trauma repair. A press release reports that the single-arm clinical trial was a success and showed that the HAV in this study had higher rates of patency, and lower rates of amputation and infection, [&#8230;] The post Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel in treatment of patients with vascular trauma appeared first on Vascular News .

## Lien source

https://vascularnews.com/humacyte-announces-positive-top-line-results-from-phase-2-3-trial-of-human-acellular-vessel-in-treatment-of-patients-with-vascular-trauma/
